204
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Comparison of Spectral Domain Optical Coherence Tomography (SD OCT) Findings with Laser Flare Photometry (LFP) Measurements in Behçet’s Uveitis

ORCID Icon &
Pages 194-199 | Received 19 Jul 2018, Accepted 23 Nov 2018, Published online: 17 Dec 2018

REFERENCES

  • Evereklioglu C. Regarding the naming dilemma of Behçet disease in the 21st century. Oral Dis. 2007;13(1):117–121. doi:10.1111/j.1601-0825.2006.01298.x.
  • Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50(4):297–350. doi:10.1016/j.survophthal.2005.04.009.
  • Bilgici B, Bedir A, Şentürk N, Alvur M, Aydin F, Turanli AY. Genotoxicity assessment using comet assay in Behcet’s disease patients. Mutat Res. 2005;578(1):170–174. doi:10.1016/j.mrfmmm.2005.05.011.
  • Ustün C. A Famous Turkish Dermatologist, Dr. Hulusi Behçet. European Journal of Dermatology. 2002;5(12):469–470.
  • Guex-Crosier Y, Pittet N, Herbort CP. Evaluation of laser flare-cell photometry in the appraisal and management of intraocular inflammation in uveitis. Ophthalmology. 1994;101:728–735.
  • Gonzales CA, Ladas JG, Davis JL, Feuer WJ, Holland GN. Relationships between laser flare photometry values and complications of uveitis. Arch Ophthalmol. 2001;119:1763–1769.
  • Guex-Crosier Y, Pittet N, Herbort CP. Sensitivity of laser flare photometry to monitor inflammation in uveitis of the posterior segment. Ophthalmology. 1995;102:613–621.
  • Tugal-Tutkun I, Yalçındağ FN, Herbort CP. Laser flare photometry and its use in uveitis. Expert Rev Ophthalmol. 2012;7(5):449–457. doi:10.1586/eop.12.47.
  • Tugal-Tutkun I, Cingü K, Kir N, Yeniad B, Urgancioglu M, Gül A. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet uveitis. Graefes Arch Clin Exp Ophthalmol. 2008;246(8):1169–1177. doi:10.1007/s00417-008-0823-6.
  • Yang P, Fang W, Huang X, Zhou H, Wang L, Jiang B. Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet’s disease. Int Ophthalmol. 2010;30(5):485–489. doi:10.1007/s10792-008-9229-z.
  • Yalcindag FN, Bingol Kiziltunc P, Savku E. Evaluation of intraocular inflammation with laser flare photometry in Behçet uveitis. Ocul Immunol Inflamm. 2017;25(1):41–45. doi:10.3109/09273948.2015.1108444.
  • Akduman L. Can we be more objective in determining the response to treatment in uveitis patients aside from recording anterior chamber reaction? Ocul Immunol Inflamm. 2009;17(4):265–266. doi:10.1080/09273940802702587.
  • Keane PA, Karampelas M, Sim DA, et al. Objective measurement of vitreous inflammation using optical coherence tomography. Ophthalmology. 2014;121(9):1706–1714. doi:10.1016/j.ophtha.2014.03.006.
  • Onal S, Uludag G, Oray M, et al. Quantitative analysis of structural alterations in the choroid of patients with active Behcet uveitis. Retina. 2018;38(4):828–840. doi:10.1097/IAE.0000000000001587.
  • Wei WB, Xu L, Jonas JB, et al. Subfoveal choroidal thickness: the Beijing eye study. Ophthalmology. 2013;120(1):175–180. doi:10.1016/j.ophtha.2012.07.048.
  • Matsuo T, Sato Y, Shiraga F, Shiragami C, Tsuchida Y. Choroidal abnormalities in Behçet disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy1. Ophthalmology. 1999;106(2):295–300. doi:10.1016/S0161-6420(99)90069-6.
  • Matsuda N, Ogura Y, Nishiwaki H, et al. Visualization of leukocyte dynamics in the choroid with indocyanine green. Invest Ophthalmol Vis Sci. 1996;37(11):2228–2233.
  • Atmaca L, Sonmez P. Fluorescein and indocyanine green angiography findings in Behçet’s disease. British J Ophthalmol. 2003;87:1466–1468.
  • Kim M, Kim H, Kwon HJ, Kim SS, Koh HJ, Lee SC. Choroidal thickness in Behcet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci. 2013;54(9):6033–6039. doi:10.1167/iovs.13-12231.
  • Ishikawa S, Taguchi M, Muraoka T, et al. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behcet’s disease. British J Ophthalmol. 2014;98:1508–1513.
  • Coskun E, Gurler B, Pehlivan Y, Kisacik B, Okumus S, Yayuspay? R, Onat AM. Enhanced depth imaging optical coherence tomography findings in Behçet disease. Ocul Immunol Inflamm. 2013;21(6):440–445. doi:10.3109/09273948.2013.817591.
  • Yesilirmak N, Lee W-H, Gur Gungor S, Yaman Pinarci E, Akkoyun I, Yilmaz G. Enhanced depth imaging optical coherence tomography in patients with different phases of Behcet’s panuveitis. Can J Ophthalmol. 2017;52(1):48–53. doi:10.1016/j.jcjo.2016.07.020.
  • Karadag AS, Bilgin B, Soylu MB. Comparison of optical coherence tomographic findings between Behcet disease patients with and without ocular involvement and healthy subjects. Arq Bras Oftalmol. 2017;80(2):69–73. doi:10.5935/0004-2749.20170018.
  • Ataş M, Yuvacı İ, Demircan S, et al. Evaluation of the macular, peripapillary nerve fiber layer and choroid thickness changes in Behçet’s disease with spectral-domain OCT. J Ophthalmol. 2014;2014:865394. doi:10.1155/2014/865394.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.